5-[[4-(pyrrolidin-3-ylmethylamino)-6-(trifluoromethyl)pyrimidin-2-yl]amino]pyridine-2-carbonitrile
C16H16F3N7 — CID 150547999
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[4-(pyrrolidin-3-ylmethylamino)-6-(trifluoromethyl)pyrimidin-2-yl]amino]pyridine-2-carbonitrile
5-[[4-(pyrrolidin-3-ylmethylamino)-6-(trifluoromethyl)pyrimidin-2-yl]amino]pyridine-2-carbonitrile (PubChem CID 150547999) has the molecular formula C16H16F3N7 and a molecular weight of 363.35 g/mol. Its IUPAC name is 5-[[4-(pyrrolidin-3-ylmethylamino)-6-(trifluoromethyl)pyrimidin-2-yl]amino]pyridine-2-carbonitrile.
Molecular Properties
| Compound Name | 5-[[4-(pyrrolidin-3-ylmethylamino)-6-(trifluoromethyl)pyrimidin-2-yl]amino]pyridine-2-carbonitrile |
|---|---|
| PubChem CID | 150547999 |
| Molecular Formula | C16H16F3N7 |
| Molecular Weight | 363.35 g/mol |
| Exact Mass | 363.14 |
| IUPAC Name | 5-[[4-(pyrrolidin-3-ylmethylamino)-6-(trifluoromethyl)pyrimidin-2-yl]amino]pyridine-2-carbonitrile |
| SMILES | N#Cc1ccc(Nc2nc(NCC3CCNC3)cc(C(F)(F)F)n2)cn1 |
| InChI | InChI=1S/C16H16F3N7/c17-16(18,19)13-5-14(23-8-10-3-4-21-7-10)26-15(25-13)24-12-2-1-11(6-20)22-9-12/h1-2,5,9-10,21H,3-4,7-8H2,(H2,23,24,25,26) |
| InChIKey | IHGRRMWQJCUADR-UHFFFAOYSA-N |
| XLogP | 2.53 |
| TPSA | 98.55 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 363.35 |
| LogP ≤ 5 | 2.53 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 150547999 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.